Has Amer Ardati, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,849 in general payments to Amer Ardati, MD across 158 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amer Ardati, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amer Ardati, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amer Ardati, MD

Interventional Cardiology · Chicago, ILNPI 1801096656

Payments from drug & device makers

$28,849in general payments, 2019–2025

Across 158 payments — averaging $182.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$11K
Cardiovascular Systems Inc.$8K
Boston Scientific$3K
Medtronic$2K
Abiomed$2K
Inari Medical, Inc.$1K
plus $3K from 17 others

What the payments were for

Consulting fees$4,05014%
Speaking & faculty fees$13,49047%
Travel & lodging$3,02410%
Food & beverage$8,20128%
Education$840%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	27	$11,170
Cardiovascular Systems Inc.	17	$7,699
Boston Scientific	11	$2,532
Medtronic(2 entities)	30	$1,858
Abiomed	16	$1,558
Inari Medical, Inc.	10	$1,181
Edwards Lifesciences	11	$1,059
BD	4	$268
Biotronik Inc.	8	$266
Stryker	2	$217
Teleflex LLC	3	$201
Philips North America LLC	3	$173
W. L. Gore & Associates, Inc.	1	$160
Cardiva Medical, Inc.	3	$140
Chiesi USA, Inc.	1	$84
Johnson & Johnson	2	$60
Angiodynamics, Inc.	1	$48
Surmodics, Inc.	2	$45
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$33
Penumbra, Inc.	1	$32
Argon Medical Devices, Inc.	1	$24
Amgen	1	$24
Livanova USA, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Xience V coronary stent system$6,224
Coronary Orbital Atherectomy System$6,047
Diamondback Coronary$2,583
AVVIGO Guidance System$1,726
DRAGONFLY OPSTAR$1,500
FLOWTRIEVER CATHETER, S$1,397
COREVALVE EVOLUT R$1,227
Impella$1,197
Dragonfly OCT$1,000
CT THROMBECTOMY SYSTEM KIT$511
SAPIEN 3 Ultra RESILIA$511
Optis Coronary Imaging System$268
GENERAL - THERAPIES$265
STINGRAY$256
Xience Sierra Coronary Stent System$255
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$190
Xience Sierra Coronary Stent$160
GORE CARDIOFORM Septal Occluder$160
FlowTriever$157
XIENCE V$146

How this compares

$28,849 in reported general payments places this provider in the 70th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois →

Medicare billing

Part B allowed, 2024

$45,446

Medicare patients

272

Services billed

534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	19	$24,218
Repatha SureclickEvolocumab	37	$18,904
Praluent PenAlirocumab	24	$11,800
BrilintaTicagrelor	12	$5,425
Rosuvastatin Calcium	47	$479
Atorvastatin Calcium	83	$469
Carvedilol	41	$321
Metoprolol Succinate	25	$266
Spironolactone	31	$235
Losartan Potassium	37	$217
Ezetimibe	19	$197
Amlodipine Besylate	28	$130
Lisinopril	27	$93

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Chicago

Charles DavidsonChicago$5.8M
Atman ShahChicago$794K
Laura DavidsonChicago$661K
Hussam SuradiChicago$455K
Fareed Moses ColladoChicago$278K
Keith BenzulyChicago$271K
David StewartChicago$241K
Sandeep KhoslaChicago$228K
Daniel SchimmelChicago$221K
Ranya SweisChicago$120K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →